Literature DB >> 12711645

Survey of tangential field planning and dose distribution in the UK: background to the introduction of the quality assurance programme for the START trial in early breast cancer.

E A Winfield1, A Deighton, K Venables, P J Hoskin, E G A Aird.   

Abstract

A background survey of UK breast radiotherapy techniques was performed prior to the introduction of the quality assurance programme for the Standardization of Radiotherapy (START) trial in breast cancer, a UK multicentre randomized trial of different dose fractionations for breast radiotherapy. Analysis of patient treatment plans was performed at this initial stage of the quality assurance programme to ensure eventual uniformity of treatment within the randomized trial and hence ensure reliable end results. As an integral part of this initial survey, three patient outlines of different size and shape were circulated between November 1997 and January 1998 to 56 UK radiotherapy centres. Dose distributions were produced according to the routine planning protocol of each department to provide information on treatment planning techniques. Criteria used for treatment plan production and the resultant dose distributions were analysed. The dose distributions varied between centres. Dose inhomogeneity of no more than 10% was achieved, on the central axis, for all chest wall and medium breast size plans. The number of larger breast size distributions exceeding a 10% dose gradient across the treatment volume was 54% (26). Most centres in the UK determine the breast dose distribution by planning on a two-dimensional contour taken along the central plane of the breast. Variation in the breast contour either side of this central plane is not taken into account. Care with plan optimization by selecting the most appropriate beam parameters can lead to an improvement in breast dosimetry.

Entities:  

Mesh:

Year:  2003        PMID: 12711645     DOI: 10.1259/bjr/59091776

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  3 in total

1.  Quality assurance analysis of participating centres' protocol compliance to a UK multicentre hypofractionated breast (FAST) trial.

Authors:  Y Tsang; K Venables; J Yarnold
Journal:  Br J Radiol       Date:  2012-01-31       Impact factor: 3.039

Review 2.  Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?

Authors:  Mareike K Thompson; Philip Poortmans; Anthony J Chalmers; Corinne Faivre-Finn; Emma Hall; Robert A Huddart; Yolande Lievens; David Sebag-Montefiore; Charlotte E Coles
Journal:  Br J Cancer       Date:  2018-07-31       Impact factor: 7.640

3.  Breast clinical target volume: HU-based glandular CTVs and ESTRO CTVs in modern and historical radiotherapy treatment planning.

Authors:  Marciana Nona Duma; Theresa Kulms; Stefan Knippen; Tobias Teichmann; Andrea Wittig
Journal:  Strahlenther Onkol       Date:  2021-09-03       Impact factor: 3.621

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.